Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Jacqui McCoy"'
Autor:
Cecilia Pynaker, Jacqui McCoy, Jane Halliday, Sharon Lewis, David J. Amor, Susan P. Walker, Lisa Hui, On behalf of the PALM cohort study group
Publikováno v:
BMC Pediatrics, Vol 24, Iss 1, Pp 1-11 (2024)
Abstract Background There are no established guidelines for the follow up of infants born after a prenatal diagnosis of a genomic copy number variant (CNV), despite their increased risk of developmental issues. The aims of this study were (i) to dete
Externí odkaz:
https://doaj.org/article/f567dae251164b458efae9ad27693720
Publikováno v:
Addiction (Abingdon, England)REFERENCES. 117(3)
AIM To evaluate and document the impacts of re-scheduling codeine to a prescription-only medication in Australia in February 2018. DESIGN Prospective cohort study. Participants completed an on-line survey with a range of outcome measures at four time
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fc4cf3cd9cb60ae626b696d49230df82
https://pubmed.ncbi.nlm.nih.gov/34622497
https://pubmed.ncbi.nlm.nih.gov/34622497
Publikováno v:
Drug and Alcohol Review. 37:257-261
Introduction and Aims. In December 2016, the Australian Therapeutic Goods Administration announced that over-the-counter (OTC) codeine would be available by prescription-only in February 2018. Prior to this announcement, the authors aimed to evaluate
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b41e82c87a37fc0297a15fae8d7f897a
https://doi.org/10.1111/dar.12568
https://doi.org/10.1111/dar.12568
BACKGROUND On February 1, 2018, Australia rescheduled codeine to a prescription-only medication. Many concerns were associated with this change, including increased financial costs, reduced service accessibility, the potential for poorer pain managem
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::36247b127af255ec35b4753504f89efa
https://doi.org/10.2196/preprints.15540
https://doi.org/10.2196/preprints.15540
Publikováno v:
JMIR Research Protocols, Vol 9, Iss 3, p e15540 (2020)
JMIR Research Protocols
JMIR Research Protocols
Background On February 1, 2018, Australia rescheduled codeine to a prescription-only medication. Many concerns were associated with this change, including increased financial costs, reduced service accessibility, the potential for poorer pain managem
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c4165e3487d6c9832e7abc1d86501cb8
https://doi.org/10.2196/15540
https://doi.org/10.2196/15540
Publikováno v:
Drug and alcohol review. 37(2)
In December 2016, the Australian Therapeutic Goods Administration announced that over-the-counter (OTC) codeine would be available by prescription-only in February 2018. Prior to this announcement, the authors aimed to evaluate attitudes among Austra
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::5aa9417d1a78475255016d08a9a69488
https://pubmed.ncbi.nlm.nih.gov/28597531
https://pubmed.ncbi.nlm.nih.gov/28597531